The S protein, a large trimeric transmembrane glycoprotein, forms a distinctive crown-like structure on the virus's surface, earning its name from its unique shape characterized by prominent spikes. This protein comprises two functional subunits: S1 and S2. The S1 subunit features two essential structural domains, namely the Receptor Binding Domain (RBD) and the N-terminal Domain (NTD). The S2 subunit, on the other hand, comprises three domains: the Heptad Repeat (HR), the Central Helix (CH), and the Connector Domain (CD). The primary function of the S protein is to facilitate the entry and infection of viruses into host cells. This is achieved through its interaction with specific receptors on the surface of host cells. In the case of SARS-CoV-2, the S protein binds to the ACE2 receptor present on human cells, initiating the infection process. The S1 subunit is responsible for recognizing and binding to receptors on the host cell surface, while the S2 subunit mediates the fusion of the virus envelope with the host cell membrane, enabling the injection of the virus's genetic material into the cell and achieving infection. The signaling pathway of the S protein primarily involves its interaction with host cell receptors and the membrane fusion process. When the RBD region of the S protein binds to the ACE2 receptor on the host cell surface, it triggers a series of intracellular signaling events. These events may involve various intracellular molecules and pathways, ultimately leading to the fusion of the virus envelope with the host cell membrane, the release of the virus's genetic material, and the completion of the infection process. A comprehensive understanding of the S protein's role in the viral infection process is crucial for developing vaccines and antiviral drugs targeting coronaviruses. This knowledge provides vital information for designing effective therapeutic strategies against these pathogens.
The following S reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
S Antibodies for Homo sapiens (Human)
Code | Product Name | Species Reactivity | Application |
---|---|---|---|
CSB-PA844701ESR2HU | PCDH19 Antibody | Human | ELISA, IHC |
S Antibodies for Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Code | Product Name | Species Reactivity | Application |
---|---|---|---|
CSB-RA33245A0GMY | S Recombinant Monoclonal Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA, GICA |
CSB-RA33245A1GMY | S Recombinant Monoclonal Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA, GICA, Neutralising |
CSB-RA33245D1GMY | S Recombinant Monoclonal Antibody, Biotin conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-RA33245C1GMY | S Recombinant Monoclonal Antibody, FITC conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | |
CSB-RA33245B1GMY | S Recombinant Monoclonal Antibody, HRP conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-RA33245A2GMY | SARS-CoV-2 Spike RBD Recombinant Nanobody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA, GICA, Neutralising |
CSB-EAP33245 | SARS-CoV-2 Spike RBD Antibody Pair 1 | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | S-ELISA |
CSB-RA33245D2GMY | SARS-CoV-2 Spike RBD Recombinant Nanobody, Biotin conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-RA33245C2GMY | SARS-CoV-2 Spike RBD Recombinant Nanobody, FITC conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-RA33245B2GMY | SARS-CoV-2 Spike RBD Recombinant Nanobody, HRP conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-MA33245A2m | S Monoclonal Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-MA33245A1m | S Monoclonal Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-MA33245A0m | S Monoclonal Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-PA33245YA01GMY | S Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-PA33245YD01GMY | S Antibody, Biotin conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-PA33245YA11GMY | S Antibody | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-PA33245YB11GMY | S Antibody, HRP conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
CSB-PA33245YC11GMY | S Antibody, FITC conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | |
CSB-PA33245YD11GMY | S Antibody, Biotin conjugated | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA |
S Proteins for Homo sapiens (Human)
Code | Product Name | Source |
---|---|---|
CSB-YP844701HU CSB-EP844701HU CSB-BP844701HU CSB-EP844701HU-B |
Recombinant Human Protocadherin-19 (PCDH19), partial | Yeast E.coli Baculovirus In Vivo Biotinylation in E.coli |
CSB-MP844701HU | Recombinant Human Protocadherin-19 (PCDH19), partial | Mammalian cell |
S Proteins for Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
S ELISA Kit for Homo sapiens (Human)
Code | Product Name | Sample Types | Sensitivity |
---|---|---|---|
CSB-EL33241HU | Human SARS-CoV-2 S1 RBD IgG Antibody ELISA Kit | serum, plasma | |
CSB-EL33242HU | Human SARS-CoV-2 S1 RBD IgM Antibody ELISA Kit | serum, plasma |